JAC's EPMA Wins Technology Innovation Award

JAC have been presented with the 2009 European e-Prescription Systems Technology Innovation Award by Frost & Sullivan (F&S). The award was based on research by F&S's own analysts and recognises JAC for continuously innovating and upgrading individual disciplines of e-prescription technology.

The award citation reads: "The company's innovative technology, coupled with uncompromising customer support, contribute to JAC's success in medicines management and makes their EPMA the most trusted e-prescribing solution among the United Kingdom's (UK) hospitals. JAC's technology provides clinicians with a solution that can manage the entire medicines therapy data in one system; assuring care provider organisations that the therapy documentation is done accurately, the appropriate safety checks are carried out and the results can be reviewed in real time. With over 25 years of expertise, JAC's medicines management technologies are in phase with the changing healthcare environment."

On being presented with the award, Robert Tysall-Blay, JAC's CEO, commented: "It is very gratifying that the work done over the years in conjunction with our clients has led to the recognition it deserves. We gratefully accept this award on behalf of all our staff and valued customers."

There was even more cause for celebration on the night as Intersystems, JAC's key technology partner, received the European Hospital Information System Customer Value Leadership Award for demonstrating high levels of customer satisfaction and increasing customer loyalty and retention through its enhanced product offering and customer service.

InterSystems has topped recent industry surveys on cost effectiveness, vendor executive involvement, job performance improvement, product quality rating and on-time implementation within budget.

Philip Birchall, InterSystems' Healthcare Business Development Director, added: "InterSystems is delighted to receive this Award, as it recognises our commitment to providing market-leading, connected healthcare software supported by a life-long partnership with our healthcare customers to help them meet the continually evolving challenges of this unique marketplace."

Related news articles:

About Frost & Sullivan
Frost & Sullivan's mission is to research and analyze new market opportunities for corporate growth. They are the world leader in growth consulting and the integrated areas of technology research, market research, economic research, corporate best practices, training, customer research, competitive intelligence and corporate strategy.

www.frost.com

About JAC Computer Services
JAC Computer Services Ltd (JAC) is the leading supplier of medicines management solutions to the NHS as well as to key sites in Ireland and South Africa. JAC's UK user-base now accounts for around half of all NHS trusts in England as well as sites in Scotland, Wales and Northern Ireland.

JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated solution along with associated services. JAC is also the exclusive distributor in the UK and Ireland of ServeRx ward-based automation technologies for medicines and medical equipment.

The JAC solution for E-Prescribing and Medicines Administration (EPMA) includes integrated in-patient, out-patient and discharge prescribing with decision support for clinical checking on allergies, drug-drug interactions and therapeutic duplicates. In addition EPMA supports medicines administration recording and can be used at the patient's bedside by doctors, nurses and other clinicians.

In June 1996, JAC was acquired by Mediware Information Systems, a global provider of clinical software systems for healthcare. Mediware is publicly traded on the NASDAQ exchange in the United States (NASDAQ: MEDW) and has more than 1400 institutions worldwide using its blood and medicines management software products.

www.jac-pharmacy.co.uk

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...